161 results on '"Akre, Olof"'
Search Results
2. MP77-11 NOMOGRAM PREDICTING OPTIMAL CANDIDATES FOR BLADDER-SPARING STRATEGIES AFTER NEOADJUVANT IMMUNOTHERAPY
3. MP14-02 IDENTIFY THE OPTIMAL CANDIDATES FOR ADJUVANT ANDROGEN DEPRIVATION THERAPY AMONG PATIENTS WITH DETECTABLE PSA AFTER RADICAL PROSTATECTOMY
4. PD29-12 THE IMPACT OF THE TIME ELAPSED BETWEEN PRIMARY TREATMENT AND BCR ON CANCER SPECIFIC MORTALITY IN PATIENTS WHO EXPERIENCED BCR AFTER PRIMARY TREATMENT
5. Long-Term Oncological Outcomes after Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localized Prostate Cancer: A Single-Center, Two-Arm Prospective Study
6. Prediagnostic Prostate-specific Antigen Testing and Clinical Characteristics in Men with Lethal Prostate Cancer
7. Risk of Venous Thromboembolic Events After Surgery for Cancer
8. AI Support for Accelerating Histopathological Slide Examinations of Prostate Cancer in Clinical Studies
9. Long-Term Oncological Outcomes After Nerve-Sparing Robot-Assisted Radical Prostatectomy for High-Risk Localised Prostate Cancer: A Single-Center, Two-Arm, Prospective Study
10. Risk of Postoperative Ischemic Stroke and Myocardial Infarction in Patients Operated for Cancer
11. Assessing the Impact of Positive Surgical Margins on Mortality in Patients Who Underwent Robotic Radical Prostatectomy: 20 Years’ Report from the EAU Robotic Urology Section Scientific Working Group
12. Cohort profile: the Turin prostate cancer prognostication (TPCP) cohort
13. Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy
14. Prostate Cancer–specific and All-cause Mortality After Robot-assisted Radical Prostatectomy: 20 Years’ Report from the European Association of Urology Robotic Urology Section Scientific Working Group
15. Supplemental Table 1 from Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011
16. Supplementary Figure 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
17. Data from Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011
18. Supplementary Table 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
19. Supplementary Figure Legend from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
20. Supplementary Table 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
21. Supplemental Table 1 from Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011
22. Supplementary Figure 1 from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
23. Supplementary Figure Legend from Subtype-Specific Risk of Testicular Tumors among Immigrants and Their Descendants in Sweden, 1960 to 2007
24. Cardiovascular, bone, and metabolic health in men with castrate-resistant prostate cancer treated with androgen deprivation: a matched cohort study
25. Effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate cancer care
26. Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
27. Travel vaccines are strongly associated to reduced mortality in prostate cancer patients - a real effect or residual confounding?
28. Association of Open vs Robot-Assisted Radical Cystectomy With Mortality and Perioperative Outcomes Among Patients With Bladder Cancer in Sweden
29. The effect of digital-enabled multidisciplinary therapy conferences on efficiency and quality of the decision making in prostate-cancer care
30. Lymph swelling after radical prostatectomy and pelvic lymph node dissection
31. Prognostic Utility of the Gleason Grading System Revisions and Histopathological Factors Beyond Gleason Grade
32. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up
33. Reply to Wei Zhang So, Ziting Wang, and Ho Yee Tiong’s Letter to the Editor re: Anna Lantz, David Bock, Olof Akre, et al. Functional and Oncological Outcomes After Open Versus Robot-assisted Laparoscopic Radical Prostatectomy for Localised Prostate Cancer: 8-Year Follow-up. Eur Urol 2021;80:650–60
34. Mortality in men with castration‐resistant prostate cancer—A long‐term follow‐up of a population‐based real‐world cohort
35. 731 RISK OF ESOPHAGEAL AND GASTRIC ADENOCARCINOMA IN MEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER
36. Systematic review and meta‐analysis identify significant relationships between clinical anxiety and lower urinary tract symptoms
37. Osteonecrosis of the jaw among patients with cancer treated with denosumab or zoledronic acid: Results of a regulator‐mandated cohort postauthorization safety study in Denmark, Norway, and Sweden
38. The 90‐day cause‐specific mortality after radical prostatectomy: a nationwide population‐based study
39. Risk of esophageal and gastric adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer
40. Real world treatment utilization patterns in patients with castration-resistant prostate cancer
41. Urinary continence recovery and oncological outcomes after surgery for prostate cancer analysed by risk category: results from the LAParoscopic prostatectomy robot and open trial
42. COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial
43. Systematic review and meta-analysis: relationships between attention-deficit/hyperactivity disorder and urinary symptoms in children
44. COVIDENZA - A Prospective, Multicenter, Randomized PHASE II Clinical Trial of Enzalutamide Treatment to Decrease the Morbidity in Patients with Corona Virus Disease 2019 (COVID-19)
45. Interchangeability of light and virtual microscopy for histopathological evaluation of prostate cancer
46. Development and validation of non‐guided bladder‐neck and neurovascular‐bundle dissection modules of the RobotiX‐Mentor® full‐procedure robotic‐assisted radical prostatectomy virtual reality simulation
47. Systematic Review and Meta-Analysis Identifies Significant Relationships Between Anxiety Disorders and Daytime Lower Urinary Tract Symptoms
48. Corrigendum re “Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study” [Eur Urol 2020;77:180–8]
49. Risk of Postoperative Up Staging or Upgrading among Men with Low Risk Familial Prostate Cancer
50. Risk of Recurrent Disease 6 Years After Open or Robotic-assisted Radical Prostatectomy in the Prospective Controlled Trial LAPPRO
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.